Longitudinal Evaluation of Health Plan Cost per Venous Thromboembolism or Bleed Event in Patients With a Prior Venous Thromboembolism Event During Hospitalization-Reference-Cited by-同舟云学术

Longitudinal Evaluation of Health Plan Cost per Venous Thromboembolism or Bleed Event in Patients With a Prior Venous Thromboembolism Event During Hospitalization

Published:2005-10 Issue:8 Volume:11 Page:663-673
ISSN:1083-4087
Container-title:Journal of Managed Care Pharmacy
language:en
Short-container-title:JMCP

Author:

Bullano Michael F.,Willey Vincent,Hauch Ole,Wygant Gail,Spyropoulos Alex C.,Hoffman Lauren

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of early vs delayed use of abemaciclib combination therapy for patients with high-risk hormone receptor–positive/human epidermal growth factor receptor 2–negative early breast cancer;Journal of Managed Care & Specialty Pharmacy;2024-09

2. Direct Oral Anticoagulants for the Prevention and Treatment of Venous Thromboembolic Events in Cancer Patients: A Meta-analysis of Randomized Controlled Trials;Current Cancer Therapy Reviews;2024-01

3. Estimation of the Direct Cost of Management of Venous Thromboembolism in Three Reference Hospitals in the City of Yaoundé: A Retrospective Study over a Three-Year Period;World Journal of Cardiovascular Diseases;2024

4. Venous thromboembolism recurrence and intracranial hemorrhage in the cancer patient: A fatal course;Medical Science and Discovery;2023-10-30

5. Thromboembolic disease prevention before cancer therapy;Cardio-Oncology Practice Manual : a Companion to Braunwald 's Heart Disease;2023